Literature DB >> 7161730

Symptoms of anxiety and depression in patients undergoing chronic haemodialysis.

W J Livesley.   

Abstract

Symptoms of anxiety and depression in a sample of 82 patients undergoing chronic haemodialysis were assessed using the Symptoms of Anxiety and Depression Scale. Mean anxiety and depression scores, were found to be significantly higher than those of normal subjects. The frequency of personal disturbance and personal illness were also higher in the patient sample. Examination of the effects of demographic, illness and treatment variables on the questionnaire scores and categories revealed that women had higher anxiety scores than men, and that they were more frequently personally disturbed and personally ill; the effects of other variables were not significant. Factor analysis of the symptoms measured by the scale revealed four factors: anxiety, suicidal ideation, mood intensity, and ruminative anxiety.

Entities:  

Mesh:

Year:  1982        PMID: 7161730     DOI: 10.1016/0022-3999(82)90072-1

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  4 in total

1.  The effect of a single haemodialysis session on functional mobility in older adults: a pilot study.

Authors:  Rebecca J A Sims; Rachel Taylor; Tahir Masud; Simon Roe; Michael J D Cassidy; Simon Mockett
Journal:  Int Urol Nephrol       Date:  2007-09-26       Impact factor: 2.370

2.  The increasing number of older patients with renal disease.

Authors:  R J A Sims; M J D Cassidy; T Masud
Journal:  BMJ       Date:  2003-08-30

3.  Depressive symptomatology in children and adolescents with chronic renal insufficiency undergoing chronic dialysis.

Authors:  Edith G Hernandez; Reyner Loza; Horacio Vargas; Mercedes F Jara
Journal:  Int J Nephrol       Date:  2011-09-20

4.  Comparison of the CBA-H and SF-36 for the screening of the psychological and behavioural variables in chronic dialysis patients.

Authors:  Concetta De Pasquale; Daniela Conti; Maria Luisa Pistorio; Pasquale Fatuzzo; Massimiliano Veroux; Santo Di Nuovo
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.